We thank Meffert and co-workers
[1]
for their interest in our study and for providing data which support our finding
of an association between carriage of rs738409:G in patatin-like phospholipase domain-containing
3 (PNPLA3) and the risk of liver-associated mortality, at least in men.
[2]
The authors evaluated the association of rs738409:G with mortality in adults participating
in a population-based health study in Pomerania. The included population of 4,081
was sub-classified by sex and by the absence/presence of hepatic steatosis on ultrasound.
Participants were censored at death or when lost to follow-up with the length of follow-up
defined as birth to censorship. The median follow-up period was 11.3 (interquartile
range: 10.6–11.8) years, though this is difficult to equate with the definition of
the follow-up period provided. In men, carriage of rs738409:G was associated with
a fourfold increase in the hazard of liver-disease-related mortality; there were too
few events in women for analysis. These data corroborate not only our findings that
carriage of rs738409:G is a negative risk factor for survival,
[2]
but also the reported association with a reduction in survival in people listed for
liver transplantation
[3]
and in those with cirrhosis and hepatocellular carcinoma.
[4]
The authors also showed that, in men, carriage of rs738409:G was associated with
a decrease in the risk of death from coronary artery disease; there was no such effect
in women.
[1]
Liu and colleagues
[5]
recently reported in an exome-wide association study in >300,000 individuals that
carriage of rs738409:G was associated with a lower risk of coronary artery disease,
corroborating this finding, although sex-specific data were not provided.- Liu D.J.
- Peloso G.M.
- Yu H.
- Butterworth A.S.
- Wang X.
- Mahajan A.
- et al.
Exome-wide association study of plasma lipids in >300,000 individuals.
Nat Genet. 2017; https://doi.org/10.1038/ng.3977
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of HepatologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The PNPLA3 SNP rs738409:G allele is associated with increased liver disease-associated mortality but reduced overall mortality in a population based cohort.J Hepatol. 2018; 68: 858-860
- Homozygosity for rs738409: G in PNPLA3 is associated with increased mortality following an episode of severe alcoholic hepatitis.J Hepatol. 2017; 67: 120-127
- PNPLA3 in end-stage liver disease: alcohol consumption, hepatocellular carcinoma development, and transplantation-free survival.J Gastroenterol Hepatol. 2014; 29: 1477-1484
- PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma.PLoS One. 2013; 8: e75982
- Exome-wide association study of plasma lipids in >300,000 individuals.Nat Genet. 2017; https://doi.org/10.1038/ng.3977
- Prednisolone or pentoxifylline for alcoholic hepatitis.N Engl J Med. 2015; 372: 1619-1628
- Prognostic factors in cirrhosis identified by Cox's regression model.Hepatology. 1983; 3: 889-895
- Survival and prognostic indicators in compensated and decompensated cirrhosis.Dig Dis Sci. 1986; 31: 468-475
- Compensated cirrhosis: natural history and prognostic factors.Hepatology. 1987; 7: 122-128
- Decreasing mortality among Danish alcoholic cirrhosis patients: a nationwide cohort study.Am J Gastroenterol. 2016; 111: 817-822
- Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi).Hepatology. 1996; 23: 1041-1046
- Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis.Hepatology. 2006; 44: 823-835
- Gender differences in genetic risk profiles for cardiovascular disease.PLoS One. 2008; 3: e3615
Article info
Publication history
Published online: December 11, 2017
Identification
Copyright
© 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.